The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Identification of a Recombinant Live Attenuated Respiratory Syncytial Virus Vaccine Candidate That Is Highly Attenuated in Infants
Abstract
BACKGROUND: Recombination technology can be used to create live attenuated respiratory syncytial virus (RSV) vaccines that contain combinations of known attenuating mutations. METHODS: Two live attenuated, recombinantly derived RSV vaccine candidates, rA2cp248/404 Delta SH and rA2cp248/404/1030 Delta SH, were evaluated in 31 adults and in 95 children >/=6 months old. rA2cp248/404/1030 Delta SH was subsequently evaluated in 44 infants 1-2 months old. These vaccine candidates share 4 attenuating genetic elements and differ only in a missense mutation (1030) in the polymerase gene. RESULTS: Both vaccines were highly attenuated in adults and RSV-seropositive children and were well tolerated and immunogenic in RSV-seronegative children. Compared with that of rA2cp248/404 Delta SH, replication of rA2cp248/404/1030 Delta SH was restricted in RSV-seronegative children (mean peak titer, 10(4.3) vs. 10(2.5) plaque-forming units [pfu]/mL), indicating that the 1030 mutation had a potent attenuating effect. Although rA2cp248/404/1030 Delta SH was well tolerated in infants, only 44% of infants who received two 10(5.3)-pfu doses of vaccine had detectable antibody responses. However, replication after administration of the second dose was highly restricted, indicating that protective immunity was induced. At least 4 of 5 attenuating genetic elements were retained in recovered vaccine viruses. CONCLUSIONS: rA2cp248/404/1030 Delta SH is the first RSV vaccine candidate to be sufficiently attenuated in young infants. Additional studies are needed to determine whether rA2cp248/404/1030 Delta SH can induce protective immunity against wild-type RSV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
KIM, H. W., CANCHOLA, J. G., BRANDT, C. D., PYLES, G., CHANOCK, R. M., JENSEN, K., & PARROTT, R. H. (1969) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120955 · Cited by 1,981
Chanock, R. M., Kim, H. W., Brandt, C., & Parrott, R. H. (1976) · Viral Infections of Humans · doi:10.1007/978-1-4613-3988-5_17 · Cited by 1,085
KAPIKIAN, A. Z., MITCHELL, R. H., CHANOCK, R. M., SHVEDOFF, R. A., & STEWART, C. E. (1969) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120954 · Cited by 1,033
Henderson, F. W., Collier, A. M., Clyde, W. A., & Denny, F. W. (1979) · New England Journal of Medicine · doi:10.1056/nejm197903083001004 · Cited by 705
RESPIRATORY VIRUS IMMUNIZATION
FULGINITI, V. A., ELLER, J. J., SIEBER, O. F., JOYNER, J. W., MINAMITANI, M., & MEIKLEJOHN, G. (1969) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120956 · Cited by 607
Collins, P. L., Hill, M. G., Camargo, E., Grosfeld, H., Chanock, R. M., & Murphy, B. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11563 · Cited by 450
Self-citation(2019) · Canadian Family Practice Guidelines · doi:10.1891/9780826194985.0134 · Cited by 336
Wright, P. F., Karron, R. A., Belshe, R. B., Thompson, J., Crowe, Jr., Boyce, T. G., Halburnt, L. L., Reed, G. W., Whitehead, S. S., Anderson, E. L., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315859 · Cited by 307
Self-citationWhitehead, S. S., Bukreyev, A., Teng, M. N., Firestone, C.-Y., St. Claire, M., Elkins, W. R., Collins, P. L., & Murphy, B. R. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.3438-3442.1999 · Cited by 237
Self-citationCOATES, H. V., ALLING, D. W., & CHANOCK, R. M. (1966) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120586 · Cited by 233
Clements, M. L., & Murphy, B. R. (1986) · Journal of Clinical Microbiology · doi:10.1128/jcm.23.1.66-72.1986 · Cited by 230
Self-citationKarron, R. A., Wright, P. F., Crowe, Jr., Clements‐Mann, M. L., Thompson, J., Makhene, M., Casey, R., & Murphy, B. R. (1997) · The Journal of Infectious Diseases · doi:10.1086/514138 · Cited by 208
Self-citationMurphy, B. R., Alling, D. W., Snyder, M. H., Walsh, E. E., Prince, G. A., Chanock, R. M., Hemming, V. G., Rodriguez, W. J., Kim, H. W., & Graham, B. S. (1986) · Journal of Clinical Microbiology · doi:10.1128/jcm.24.5.894-898.1986 · Cited by 197
Self-citationJohnson, P. R., Feldman, S., Thompson, J. M., Mahoney, J. D., & Wright, P. F. (1986) · Journal of Infectious Diseases · doi:10.1093/infdis/154.1.121 · Cited by 193
Self-citationMurphy, B. R., Hall, S. L., Kulkarni, A. B., Crowe, J. E., Collins, P. L., Connors, M., Karron, R. A., & Chanock, R. M. (1994) · Virus Research · doi:10.1016/0168-1702(94)90059-0 · Cited by 131
Self-citationKim, H. W., Arrobio, J. O., Pyles, G., Brandt, C. D., Camargo, E., Chanock, R. M., & Parrott, R. H. (1971) · PEDIATRICS · doi:10.1542/peds.48.5.745 · Cited by 117
Prospects for a respiratory syncytial virus vaccine
Hall, C. B. (1994) · Science · doi:10.1126/science.7915433 · Cited by 107
Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants
Wright, P. F., Shinozaki, T., Fleet, W. F., SELL, S. H. W., Thompson, J., & Karzon, D. T. (1976) · The Journal of Pediatrics · doi:10.1016/s0022-3476(76)81044-x · Cited by 103
Self-citationCrowe, J. E., Bui, P. T., Siber, G. R., Elkins, W. R., Chanock, R. M., & Murphy, B. R. (1995) · Vaccine · doi:10.1016/0264-410x(94)00074-w · Cited by 102
Self-citationCrowe, J. E., Bui, P., DAVIS, A., Chanock, R. M., & Murphy, B. R. (1994) · Vaccine · doi:10.1016/0264-410x(94)90286-0 · Cited by 99
Self-citationEvaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infants
Karron, R. A., Makhene, M., Gay, K., WILSON, M. H., Clements, M. L., & Murphy, B. R. (1996) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199608000-00003 · Cited by 98
Self-citationA live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants
Karron, R. A., Belshe, R. B., Wright, P. F., Thumar, B., BURNS, B., Newman, F. K., Cannon, J. C., Thompson, J., Tsai, T. F., Paschalis, M., et al. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000066244.31769.83 · Cited by 93
Self-citationWhitehead, S. S., Juhász, K., Firestone, C.-Y., Collins, P. L., & Murphy, B. R. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.4467-4471.1998 · Cited by 88
Self-citationWhitehead, S. S., Firestone, C.-Y., Karron, R. A., Crowe, J. E., Elkins, W. R., Collins, P. L., & Murphy, B. R. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.871-877.1999 · Cited by 88
Self-citationCollins, P. L., Whitehead, S. S., Bukreyev, A. A., Fearns, R., Teng, M. N., Juhász, K., Chanock, R. M., & Murphy, B. R. (1999) · Advances in virus research · doi:10.1016/s0065-3527(08)60374-7 · Cited by 87
Self-citationCrowe, J. E., Bui, P., London, W. T., Davis, A. R., Hung, P. P., Chanock, R. M., & Murphy, B. R. (1994) · Vaccine · doi:10.1016/0264-410x(94)90218-6 · Cited by 83
Self-citationGonzález, I. M., Karron, R. A., Eichelberger, M. C., Walsh, E. E., DeLaGarza, V. W., Bennett, R., Chanock, R. M., Murphy, B. R., Clements‐Mann, M. L., & Falsey, A. R. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00527-7 · Cited by 79
Self-citationWhitehead, S. S., Firestone, C.-Y., Collins, P. L., & Murphy, B. R. (1998) · Virology · doi:10.1006/viro.1998.9248 · Cited by 74
Self-citationHall, S. L., Stokes, A., Tierney, E. L., London, W. T., Belshe, R. B., Newman, F. K., & Murphy, B. R. (1992) · Virus Research · doi:10.1016/0168-1702(92)90049-f · Cited by 71
Self-citationKarron, R. A., Steinhoff, M. C., Subbarao, K., WILSON, M. H., MACLEOD, K., Clements, M. L., Fries, L. F., & Murphy, B. R. (1995) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199501000-00002 · Cited by 64
Self-citationEffective Immunization with Live Attenuated Influenza A Virus Can Be Achieved in Early Infancy
Clements, M. L., Makhene, M., Karron, R. A., Murphy, B. R., Steinhoff, M. C., Subbarao, K., Wilson, M. E. H., & Wright, P. F. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.1.44 · Cited by 52
Self-citationKrempl, C. D., Murphy, B. R., & Collins, P. L. (2002) · Journal of Virology · doi:10.1128/jvi.76.23.11931-11942.2002 · Cited by 49
Self-citationMurphy, B. R., Park, E. J., Gottlieb, P., & Subbarao, K. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00031-5 · Cited by 38
Self-citationMcAuliffe, J. M., Surman, S. R., Newman, J. T., Riggs, J. M., Collins, P. L., Murphy, B. R., & Skiadopoulos, M. H. (2004) · Journal of Virology · doi:10.1128/jvi.78.4.2029-2036.2004 · Cited by 33
Self-citationA Cold-Adapted Mutant of Parainfluenza Virus Type 3 Is Attenuated and Protective in Chimpanzees
Hall, S. L., Sarris, C. M., Tierney, E. L., London, W. T., & Murphy, B. R. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.4.958 · Cited by 31
Self-citation
Cited by
Nair, H., Nokes, D. J., Gessner, B. D., Dherani, M., Madhi, S. A., Singleton, R. J., O'Brien, K. L., Roca, A., Wright, P. F., Bruce, N., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60206-1 · Cited by 2,773
Self-citationViral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis
Collins, P. L., & Graham, B. S. (2008) · Journal of Virology · doi:10.1128/jvi.01625-07 · Cited by 486
Self-citationCollins, P. L., & Melero, J. A. (2011) · Virus Research · doi:10.1016/j.virusres.2011.09.020 · Cited by 455
Self-citationEpidemiology of Human Metapneumovirus
Kahn, J. S. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00014-06 · Cited by 355
“Live recombinant RSV vaccine candidates containing attenuating mutations and lacking the SH gene are currently in clinical trials (59).”
BackgroundThe role of viruses in acute exacerbations of asthma
Jackson, D. J., & Johnston, S. L. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.04.021 · Cited by 351
“Recent attention has focused on live attenuated vaccines and developing subunit vaccines for RSV in combination with TH1-inducing adjuvants, although neither approach is likely to be ready for clinical use for some time.(109,110) Palivizumab, an mAb against the RSV fusion protein, is the only US Food and Drug Administ…”
Background
Metadata
- Authors
- Karron, R. A., Wright, P. F., Belshe, R. B., Thumar, B., Casey, R., Newman, F., Polack, F. P., Randolph, V. B., Deatly, A., Hackell, J., Gruber, W., Murphy, B. R., & Collins, P. L.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-04
- Volume
- 191
- Issue
- 7
- Pages
- 1093-1104
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2106450636
- Cited by
- 287
- References
- 35
- FWCI
- 13.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.